Product not available in United States. The product information shown is from the Canada catalog.

Active Sustain

Xymogen
$N/A (MSRP)
Create account for pricing

Already have an account? Log in

Active Sustain (120 capsules)
SKU: XY-NEURO

Description

Provides antioxidants for the maintenance of good health

Helps to maintain and/or support cardiovascular health


Suggested Use: Adults: Take 2 capsules once daily with a meal providing protein, or as directed by a healthcare practitioner.

Serving Size: 2 Capsules

Medicinal Ingredients
N-Acetyl L-Carnitine Hydrochloride ... 100 mg
N-Acetyl-L-Cysteine ... 37.5 mg
truebroc® Broccoli Seed Extract ... 28.85 mg
(Brassica oleracea var. italica – seed, providing 3.75 mg Glucoraphanin)
SharpPS® GREEN Phosphatidylserine ... 25 mg
(from Helianthus annuus – sunflower)
Coenzyme Q10 ... 25 mg
(from microorganisms – whole cell for biosynthesis)
DL-Alpha-Lipoic Acid ... 25 mg

Non-Medicinal Ingredients: Calcium phosphate tribasic, Hypromellose, Stearic acid, Magnesium stearate, Silicon dioxide, Calcium silicate
Consult a healthcare practitioner for use beyond 6 months. Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding; if you are taking blood pressure medication, nitroglycerin, or antibiotics; or if you have diabetes or cystinuria. Caution: Do not use if you have primary systemic L-carnitine deficiency or secondary L-carnitine deficiency (inborn errors of metabolism) for which supplementation is prescribed / monitored by a healthcare practitioner. Feelings of sleeplessness or over stimulation may occur; discontinue use if feeling persists or worsens. Discontinue use and consult a healthcare practitioner if symptoms persist or worsen. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner. Mild gastrointestinal symptoms (transient nausea, vomiting, abdominal cramps, and diarrhoea) have been reported. Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorders.